Combined analyses of the full and MRD-negative KIR cohorts with the full and MRD-negative CIBMTR cohorts for DFS/OS
Outcome . | HR . | 95% CI, lower limit . | 95% CI, upper limit . | P . | Overall P . | n . |
---|---|---|---|---|---|---|
KIR cohort and CIBMTR cohort | ||||||
DFS | ||||||
Donor type | ||||||
Haploidentical | 1.00 | — | — | — | .1312 | 46 |
HLA-identical sibling | 1.434 | 0.778 | 2.64 | .2478 | 526 | |
Well-matched URD | 1.448 | 0.788 | 2.661 | .2337 | 665 | |
Partially matched URD | 1.745 | 0.929 | 3.277 | .0834 | 216 | |
CB | 1.728 | 0.937 | 3.189 | .0799 | 412 | |
Ethnicity | ||||||
Hispanic | 1.00 | — | — | — | .0305 | 569 |
Non-Hispanic | 0.798 | 0.672 | 0.948 | .0101 | 1215 | |
Data missing | 0.758 | 0.502 | 1.145 | .1879 | 81 | |
Disease | ||||||
AML | 1.00 | — | — | — | .0009 | 876 |
ALL | 0.76 | 0.647 | 0.894 | .0009 | 989 | |
Disease status (≤8 mo) | ||||||
CR1 | 1.00 | — | — | — | .0004 | 1114 |
CR2 | 1.426 | 1.171 | 1.737 | .0004 | 751 | |
Disease status (>8 mo) | ||||||
CR1 | 1.00 | — | — | — | .0852 | 774 |
CR2 | 0.781 | 0.59 | 1.035 | .0852 | 499 | |
OS | ||||||
Donor type (≤4 mo) | ||||||
Haploidentical | 1.00 | — | — | — | .0001 | 46 |
HLA-identical sibling | 2.024 | 0.274 | 14.975 | .4897 | 527 | |
Well-matched URD | 2.67 | — | 19.485 | .3327 | 670 | |
Partially matched URD | 4.783 | — | 35.521 | .126 | 216 | |
CB | 5.567 | 0.769 | 40.279 | .089 | 415 | |
Donor type (>4 mo) | ||||||
Haploidentical | 1.00 | 0.408 | 1.619 | .556 | .2449 | 45 |
HLA-identical sibling | 0.813 | 0.463 | 1.813 | .8015 | 491 | |
Well-matched URD | 0.916 | 0.585 | 2.439 | .625 | 619 | |
Partially matched URD | 1.195 | 0.409 | 1.652 | .5813 | 191 | |
CB | 0.822 | 0.409 | 1.652 | .5813 | 356 | |
Ethnicity | ||||||
Hispanic | 1.00 | — | — | — | .01 | 574 |
Non-Hispanic | 0.756 | 0.618 | 0.925 | .0066 | 1218 | |
Data missing | 0.58 | 0.34 | 0.989 | .0454 | 82 | |
Disease (≤6 mo) | ||||||
AML | 1.00 | .8471 | 882 | |||
ALL | 1.03 | 0.765 | 1.385 | .8471 | 992 | |
Disease (>6 mo) | ||||||
AML | 1.00 | — | — | — | <.0001 | 741 |
ALL | 0.53 | 0.411 | 0.682 | <.0001 | 824 | |
Disease status (≤5 mo) | ||||||
CR1 | 1.00 | — | — | — | .0003 | 1119 |
CR2 | 1.813 | 1.317 | 2.496 | .0003 | 755 | |
Disease status (>5 mo) | ||||||
CR1 | 1.00 | — | — | — | .5978 | 1018 |
CR2 | 0.936 | 0.734 | 1.195 | .5978 | 652 | |
MRD−KIR cohort and MRD−CIBMTR cohort | ||||||
DFS | ||||||
Donor type | ||||||
Haploidentical | 1.00 | — | — | — | .1327 | 42 |
HLA-identical sibling | 1.636 | 0.797 | 3.355 | .1795 | 378 | |
Well-matched URD | 1.617 | 0.792 | 3.303 | .1869 | 478 | |
Partially matched URD | 2.057 | 0.978 | 4.327 | .0574 | 149 | |
CB | 1.995 | 0.971 | 4.098 | .0601 | 298 | |
Disease | ||||||
AML | 1.00 | — | — | — | .0126 | 609 |
ALL | 0.782 | 0.645 | 0.949 | .0126 | 736 | |
OS | ||||||
Donor type (≤4 mo) | ||||||
Haploidentical | 1.00 | — | — | — | .0002 | 42 |
HLA-identical sibling | 1.959 | 0.261 | 14.731 | .5134 | 379 | |
Well-matched URD | 2.219 | 0.299 | 16.486 | .4361 | 480 | |
Partially matched URD | 6.092 | 0.815 | 45.541 | .0783 | 149 | |
CB | 5.046 | 0.69 | 36.886 | .1108 | 300 | |
Donor type (>4 mo) | ||||||
Haploidentical | 1.00 | — | — | — | .4106 | 41 |
HLA-identical sibling | 0.87 | 0.371 | 2.043 | .7497 | 354 | |
Well-matched URD | 1.15 | 0.497 | 2.658 | .7441 | 443 | |
Partially matched URD | 1.374 | 0.564 | 3.344 | .4841 | 126 | |
CB | 1.061 | 0.45 | 2.499 | .8922 | 258 | |
Ethnicity | ||||||
Hispanic | 1.00 | — | — | — | .0314 | 406 |
Non-Hispanic | 0.728 | 0.567 | 0.935 | .0129 | 886 | |
Data missing | 0.613 | 0.319 | 1.181 | .1436 | 58 | |
Disease (≤6 mo) | ||||||
AML | 1.00 | — | — | — | .4472 | 612 |
ALL | 1.152 | 0.799 | 1.661 | .4472 | 738 | |
Disease (>6 mo) | ||||||
AML | 1.00 | — | — | — | <.0001 | 511 |
ALL | 0.49 | 0.354 | 0.677 | <.0001 | 611 | |
Disease status (≤5 mo) | ||||||
CR1 | 1.00 | — | — | — | .0081 | 784 |
CR2 | 1.686 | 1.145 | 2.482 | .0081 | 566 | |
Disease status (>5 mo) | ||||||
CR1 | 1.00 | — | — | — | .0512 | 711 |
CR2 | 0.73 | 0.533 | 1.002 | .0512 | 492 |
Outcome . | HR . | 95% CI, lower limit . | 95% CI, upper limit . | P . | Overall P . | n . |
---|---|---|---|---|---|---|
KIR cohort and CIBMTR cohort | ||||||
DFS | ||||||
Donor type | ||||||
Haploidentical | 1.00 | — | — | — | .1312 | 46 |
HLA-identical sibling | 1.434 | 0.778 | 2.64 | .2478 | 526 | |
Well-matched URD | 1.448 | 0.788 | 2.661 | .2337 | 665 | |
Partially matched URD | 1.745 | 0.929 | 3.277 | .0834 | 216 | |
CB | 1.728 | 0.937 | 3.189 | .0799 | 412 | |
Ethnicity | ||||||
Hispanic | 1.00 | — | — | — | .0305 | 569 |
Non-Hispanic | 0.798 | 0.672 | 0.948 | .0101 | 1215 | |
Data missing | 0.758 | 0.502 | 1.145 | .1879 | 81 | |
Disease | ||||||
AML | 1.00 | — | — | — | .0009 | 876 |
ALL | 0.76 | 0.647 | 0.894 | .0009 | 989 | |
Disease status (≤8 mo) | ||||||
CR1 | 1.00 | — | — | — | .0004 | 1114 |
CR2 | 1.426 | 1.171 | 1.737 | .0004 | 751 | |
Disease status (>8 mo) | ||||||
CR1 | 1.00 | — | — | — | .0852 | 774 |
CR2 | 0.781 | 0.59 | 1.035 | .0852 | 499 | |
OS | ||||||
Donor type (≤4 mo) | ||||||
Haploidentical | 1.00 | — | — | — | .0001 | 46 |
HLA-identical sibling | 2.024 | 0.274 | 14.975 | .4897 | 527 | |
Well-matched URD | 2.67 | — | 19.485 | .3327 | 670 | |
Partially matched URD | 4.783 | — | 35.521 | .126 | 216 | |
CB | 5.567 | 0.769 | 40.279 | .089 | 415 | |
Donor type (>4 mo) | ||||||
Haploidentical | 1.00 | 0.408 | 1.619 | .556 | .2449 | 45 |
HLA-identical sibling | 0.813 | 0.463 | 1.813 | .8015 | 491 | |
Well-matched URD | 0.916 | 0.585 | 2.439 | .625 | 619 | |
Partially matched URD | 1.195 | 0.409 | 1.652 | .5813 | 191 | |
CB | 0.822 | 0.409 | 1.652 | .5813 | 356 | |
Ethnicity | ||||||
Hispanic | 1.00 | — | — | — | .01 | 574 |
Non-Hispanic | 0.756 | 0.618 | 0.925 | .0066 | 1218 | |
Data missing | 0.58 | 0.34 | 0.989 | .0454 | 82 | |
Disease (≤6 mo) | ||||||
AML | 1.00 | .8471 | 882 | |||
ALL | 1.03 | 0.765 | 1.385 | .8471 | 992 | |
Disease (>6 mo) | ||||||
AML | 1.00 | — | — | — | <.0001 | 741 |
ALL | 0.53 | 0.411 | 0.682 | <.0001 | 824 | |
Disease status (≤5 mo) | ||||||
CR1 | 1.00 | — | — | — | .0003 | 1119 |
CR2 | 1.813 | 1.317 | 2.496 | .0003 | 755 | |
Disease status (>5 mo) | ||||||
CR1 | 1.00 | — | — | — | .5978 | 1018 |
CR2 | 0.936 | 0.734 | 1.195 | .5978 | 652 | |
MRD−KIR cohort and MRD−CIBMTR cohort | ||||||
DFS | ||||||
Donor type | ||||||
Haploidentical | 1.00 | — | — | — | .1327 | 42 |
HLA-identical sibling | 1.636 | 0.797 | 3.355 | .1795 | 378 | |
Well-matched URD | 1.617 | 0.792 | 3.303 | .1869 | 478 | |
Partially matched URD | 2.057 | 0.978 | 4.327 | .0574 | 149 | |
CB | 1.995 | 0.971 | 4.098 | .0601 | 298 | |
Disease | ||||||
AML | 1.00 | — | — | — | .0126 | 609 |
ALL | 0.782 | 0.645 | 0.949 | .0126 | 736 | |
OS | ||||||
Donor type (≤4 mo) | ||||||
Haploidentical | 1.00 | — | — | — | .0002 | 42 |
HLA-identical sibling | 1.959 | 0.261 | 14.731 | .5134 | 379 | |
Well-matched URD | 2.219 | 0.299 | 16.486 | .4361 | 480 | |
Partially matched URD | 6.092 | 0.815 | 45.541 | .0783 | 149 | |
CB | 5.046 | 0.69 | 36.886 | .1108 | 300 | |
Donor type (>4 mo) | ||||||
Haploidentical | 1.00 | — | — | — | .4106 | 41 |
HLA-identical sibling | 0.87 | 0.371 | 2.043 | .7497 | 354 | |
Well-matched URD | 1.15 | 0.497 | 2.658 | .7441 | 443 | |
Partially matched URD | 1.374 | 0.564 | 3.344 | .4841 | 126 | |
CB | 1.061 | 0.45 | 2.499 | .8922 | 258 | |
Ethnicity | ||||||
Hispanic | 1.00 | — | — | — | .0314 | 406 |
Non-Hispanic | 0.728 | 0.567 | 0.935 | .0129 | 886 | |
Data missing | 0.613 | 0.319 | 1.181 | .1436 | 58 | |
Disease (≤6 mo) | ||||||
AML | 1.00 | — | — | — | .4472 | 612 |
ALL | 1.152 | 0.799 | 1.661 | .4472 | 738 | |
Disease (>6 mo) | ||||||
AML | 1.00 | — | — | — | <.0001 | 511 |
ALL | 0.49 | 0.354 | 0.677 | <.0001 | 611 | |
Disease status (≤5 mo) | ||||||
CR1 | 1.00 | — | — | — | .0081 | 784 |
CR2 | 1.686 | 1.145 | 2.482 | .0081 | 566 | |
Disease status (>5 mo) | ||||||
CR1 | 1.00 | — | — | — | .0512 | 711 |
CR2 | 0.73 | 0.533 | 1.002 | .0512 | 492 |
Bold P-values indicate statistically significant results.